CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Paliperidone palmitate

Last Updated: July 9, 2010
Result type: Reports
Project Number: S0206
Product Line: Common Drug Review

Generic Name: Paliperidone palmitate

Brand Name: Invega Sustenna

Manufacturer: Janssen-Ortho Inc.

Indications: Schizophrenia

Submission Type: New

Project Status: Complete

Date Recommendation Issued: April 25, 2011

Recommendation Type: Do not list